Isn’t the thinking to consider switching patients from ACE inhibitors (“pril”) to ARBs (“tan”)?
so far there is no evidence that helps. Guidance from the university of washington and others says no need to switch. It would make sense changes in receptors takes a good deal of time and changing meds would likely make no difference acutely
Also ace and arbs act in essentially the same fashion so I would expect. it’s would upregulate the Ace receptors. I work in covid units in the hospital and I haven’t stopped my Ace inhibitor.